Berlin: The World Health Organization (WHO) has stated that it is discontinuing ongoing trials regarding whether or not the anti-malarial drug hydroxychloroquine is effective in treating hospitalized corona virus-infected patients. The WHO said on Saturday that it has accepted the committee’s recommendation to stop the trial of the drug monitoring committee hydroxychloroquine and the drug lopinavir/ritonavir used to treat HIV / AIDS patients.
The organization said that interim results showed that the use of hydroxychloroquine and lopinavir/ritonavir “did not reduce or moderately decrease mortality in hospitalized Kovid-19 patients”. He said that there is no “concrete evidence” of the increased mortality in patients hospitalized who were given these drugs, while “clinical laboratory results of the test” showed some safety-related indications. The WHO said the ruling would not affect prospective trials on patients who are not hospitalized or are taking the drug before or shortly after exposure to the coronavirus.
